Items where authors include "Bansi-Matharu, Loveleen"

Article

Phillips, Andrew N, Hickey, Matthew D, Shade, Starley B et al. (12 more authors) (2025) Dynamic choice HIV prevention with long-acting injectable cabotegravir pre-exposure prophylaxis in east, central, southern, and west Africa:a cost-effectiveness modelling analysis. The Lancet HIV. ISSN 2352-3018

Phillips, Andrew, Smith, Jennifer, Bansi-Matharu, Loveleen et al. (13 more authors) (2025) Potential impact and cost-effectiveness of long-acting injectable lenacapavir plus cabotegravir as HIV treatment in Africa. Nature Communications. 5760. ISSN 2041-1723

Phillips, Andrew N, Bansi-Matharu, Loveleen, van Oosterhout, Joep J et al. (27 more authors) (2025) Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa:a modelling study. The lancet. HIV. ISSN 2352-3018

Bansi-Matharu, Loveleen, Revill, Paul orcid.org/0000-0001-8632-0600, Taramusi, Issac et al. (14 more authors) (2024) The effect on HIV transmission and cost-effectiveness of programmes for female sex workers in East, Central, and Southern Africa:a modelling study. The Lancet Global Health. e1436-e1445. ISSN 2214-109X

Phillips, Andrew N, Bansi-Matharu, Loveleen, Shahmanesh, Maryam et al. (12 more authors) (2023) Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa:a modelling analysis. The Lancet Global Health. e1648-e1657. ISSN 2214-109X

Bansi-Matharu, Loveleen, Mudimu, Edinah, Martin-Hughes, Rowan et al. (27 more authors) (2022) Cost-effectiveness of voluntary medical male circumcision for HIV prevention across sub-Saharan Africa:results from five independent models. The Lancet Global Health. ISSN 2214-109X

Phillips, Andrew N, Sibanda, Euphemia, Sikwese, Kenly et al. (11 more authors) (2022) Enabling timely HIV postexposure prophylaxis access in sub-Saharan Africa. AIDS (London, England). pp. 1473-1475. ISSN 1473-5571

Phillips, Andrew N, Bansi-Matharu, Loveleen, Cambiano, Valentina et al. (8 more authors) (2021) The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa:a modelling analysis. The Lancet Global Health. e620-e627. ISSN 2214-109X

Phillips, Andrew N, Bansi-Matharu, Loveleen, Venter, Francois et al. (22 more authors) (2020) Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa:modelling to inform treatment guidelines. The Lancet HIV. ISSN 2352-3018

Phillips, Andrew, Cambiano, Valentina, Johnson, Leigh et al. (16 more authors) (2019) Potential impact and cost-effectiveness of condomless-sex-concentrated PrEP in KwaZulu-Natal accounting for drug resistance. The Journal of Infectious Diseases. jiz667. ISSN 0022-1899

Phillips, Andrew, Venter, Francois, Havlir, Diana et al. (21 more authors) (2018) Risks and benefits for use of dolutegravir-based antiretroviral drug regimens in sub Saharan Africa: a modelling study. The Lancet HIV. pp. 1-12. ISSN 2352-3018

Phillips, Andrew N., Cambiano, Valentina, Nakagawa, Fumiyo et al. (9 more authors) (2016) Cost effectiveness of potential ART adherence monitoring interventions in sub-saharan Africa. PLoS ONE. e0167654. pp. 1-20. ISSN 1932-6203

Phillips, Andrew, Cambiano, Valentina, Nakagawa, Fumiyo et al. (11 more authors) (2016) Point-of-care viral load testing for sub-Saharan Africa:informing a target product profile. Open Forum Infectious Diseases. ofw161.

Phillips, Andrew, Cambiano, Valentina, Revill, Paul orcid.org/0000-0001-8632-0600 et al. (12 more authors) (2016) Identifying key drivers of the impact of an HIV cure intervention in sub-Saharan Africa. The Journal of Infectious Diseases. ISSN 0022-1899